Description

RECRUITING FOR THE POSTITION COMMENCING 13 JULY TO 31 JANUARY 2027

What you'll be doing

We host a busy HSCT and cellular therapy service, and perform MUD and haploidentical transplants for high grade haematological malignancy as well as primary immunodeficiency syndromes. We are the national referral centre for autoimmune autologous transplant (MS and scleroderma), and participate in autoimmune and solid organ malignancy CART cells trials.

The duties and responsibilities of the position will include: